Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of minocycline on prognosis in intracerebral hemorrhage
IRCT20241118063757N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in intracerebral hemorrhage (ICH), sponsored by Urmia University of Medical Sciences. Started Feb 2026; status: completed.
02
Drugs
minocycline
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20241118063757N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241118063757N1.